Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 67, 2012 - Issue 1
18
Views
0
CrossRef citations to date
0
Altmetric
Continuing Medical Education

INFECTIONS WITH VEROTOXIN-PRODUCING ESCHERICHIA COLI O157:H7 AND OTHER SEROTYPES, INCLUDING THE OUTBREAK STRAIN O104:H4

&
Pages 7-12 | Published online: 08 Oct 2014

REFERENCES

  • Nataro JP, Bopp CA, Fields PI, et al. Escherichia, Shigella, and Salmonella. In: Versalovic J, Caroll KC, Funke G, et al., eds. Manual of Clinical Microbiology. Washington, DC: ASM Press 2011; 603–626.
  • Kaper JB, Nataro JP, Mobley HL. Pathogenic Escherichia coli. Nat Rev Microbiol 2004; 2: 123–140.
  • Nataro JP, Kaper JB. Dia rrhoeagenic Escherichia coli. Clin Microbiol Rev 1998; 11: 142–201.
  • Konowalchuk J, Speirs JI, Stavric S. Vero response to a cytotoxin of Escherichia coli. Infect lmmun 1977; 18: 775–779.
  • O'Brien AD, LaVeck GD, Thompson MR, et al. Production of Shigella dysenteriae type 1-like cytotoxin by Escherichia coli. J Infect Dis 1982; 146: 763–769.
  • Riley LW, Remis RS, Helgerson SD, et al. Hemorrhagic colitis associated with a rare Escherichia coli serotype. N Engl J Med 1983; 308: 681–685.
  • Karmali MA, Steele BT, Petric M, et al. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet 1983; 1:619–620.
  • Karmali MA, Gannon V. Sargeant JM. Verocytotoxin-producing Escherichia coli (VTEC). Vet Microbiol 2010; 140:360–370.
  • Karmali MA, Mascarenhas M, Shen S, et al. Association of genomic 0 island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Micro-biol 2003; 41:4930–4940.
  • Konczy P. Ziebell K, Mascarenhas M, et al. Genomic O island 122, locus for enterocyte effacement, and the evolution of virulent verocytotoxin-producing Escherichia coli. J Bacteriol 2008; 190: 5832–5840.
  • Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 2005; 365: 1073–1086.
  • Proesmans W. Typical and atypical hemolytic uremic syndrome. Kidney Blood Press Res 1996; 19: 205–208.
  • Piérard DCG, Proesmans W, Dediste A, et al. Hemolytic uremic syndrome in Bel-gium: incidence and association with verocytotoxin-producing Escherichia coli infection. Clin Microbiol Infect 1999; 5: 16–22.
  • Safdar N, Said A, Gangnon RE, et al. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli 0157:H7 enteritis: a meta-analysis. JAMA 2002; 288: 996–1001.
  • Melton-Celsa AR, O'Brien AD. Structure, biology, and relative toxicity of Shiga toxin family members for cells and animals, p. 121–128. In J. B. Kaper and A. D. O'Brien (eds.), Escherichia coli 0157:H7 and Other Shiga Toxin-Producing E. coli Strains. Washington D.C. ASM Press 1998; 121–139.
  • Bielaszewska M, Friedrich AW, Aldick T, et al. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin Infect Dis 2006; 43: 1160–1167.
  • Friedrich AW, Bielaszewska M, Zhang WL, et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 2002; 185: 74–84.
  • Orth D, Grif K, Khan AB, et al. The Shiga toxin genotype rather than the amount of Shiga toxin or the cytotoxicity of Shiga toxin in vitro correlates with the appearance of the hemolytic uremic syndrome. Diagn Microbiol Infect Dis 2007; 59:235–242.
  • Frankel G, Phillips AD, Rosenshine I, et al. Enteropathogenic and enterohaemor-rhagic Escherichia coli: more subversive elements. Mol Microbiol 1998; 30:911–921.
  • Garmendia J, Frankel G, Crepin VF. Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation. Infect Immun 2005; 73: 2573–2585.
  • Aldick T, Bielaszewska M, Zhang W, et al. Hemolysin from Shiga toxin-negative Escherichia coli 026 strains injures microvascular endothelium. Microbes Infect 2007; 9: 282–290.
  • Griffin PM, Tauxe RV. The epidemiology of infections caused by Escherichia coli 0157:H7, other enterohemorrhagic E. coli, and the associated hemolytic uremic syndrome. Epidemiol Rev 1991; 13: 60–98.
  • Pierard D, Stevens D, Moriau L, et al. Isolation and virulence factors of verocy-totoxin-producing Escherichia coli in human stool samples. Clin Microbiol Infect 1997; 3:531–540.
  • De Schrijver K, Buvens G, Posse B, et al. Outbreak of verocytotoxin-producing E. coli 0145 and 026 infections associated with the consumption of ice cream produced at a farm, Belgium, 2007. Euro Surveil' 2008; 13.
  • Cobbaut K, Berkvens D, Hoof K, et al. Escherichia coli 0157 prevalence in differ-ent cattle farm types and identification of potential risk factors. J Food Prot 2009; 72: 1848–1853.
  • Pennington H. Escherichia coli 0157. Lancet 2010; 376: 1428–1435.
  • Karch H, Russmann H, Schmidt H, et al. Long-term shedding and clonal turnover of enterohemorrhagic Escherichia coli 0157 in diarrheal diseases. J Clin Microbiol 1995; 33: 1602–1605.
  • Robert Koch Institute. Final presentation and evaluation of the epidemiological fincings in the EHEC 0104:H4 outbreak, Germany 2011. In: http://edoc.rki.de/documents/rki_ab/reQH531jDrGxc/PDF/23NXL3J0mOyAA.pdf
  • WHO. Outbreaks of E. coli 010:H4 infection: update 30. In: http://www.euro.who.int/en/what-we-do/health-topics/emergenciesfinternational-health-regulations/news/news/2011/07/outbreaksofe.coilo104h4-infection-update-30 2011.
  • Gault G, Weill FX, Mariani-Kurkdjian P. et al. Outbreak of haemolytic uraemic syndrome and bloody diarrhoea due to Escherichia coli 0104:H4, south-west France, June 2011. Euro Surveil' 2011; 16.
  • Frank C, Werber D, Cramer JP, et al. Epidemic Profile of Shiga-Toxin-Producing Escher-ichia coli 0104:H4 Outbreak in Germany - Preliminary Report. N Engl J Med 2011.
  • Wendel AM, Johnson DH, Sharapov U, et al. Multistate outbreak of Escherichia coli 0157:H7 infection associated with consumption of packaged spinach, August-September 2006: the Wisconsin investigation. Clin Infect Dis 2009; 48: 1079–1086.
  • Berger CN, Sodha SV, Shaw RK, et al. Fresh fruit and vegetables as vehicles for the transmission of human pathogens. Environ Microbiol 2010; 12: 2385–2397.
  • Michino H, Araki K, Minami S, et al. Massive outbreak of Escherichia con 0157:H7 infection in schoolchildren in Sakai City, Japan, associated with consumption of white radish sprouts. Am J Epidemiol 1999; 150: 787–796.
  • Scheutz F, Moller NE, Frimodt-Moller J, et al. Characteristics of the enteroag-gregative Shiga toxin/verotoxin-producing Escherichia coli 0104:H4 strain caus-ing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011. Euro Surveill 2011; 16.
  • Bielaszewska M, MelImann A, Zhang W, et al. Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect Dis 2011.
  • Morabito S, Karch H, Mariani-Kurkdjian P. et al. Enteroaggregative, Shiga toxin-producing Escherichia coli 0111:H2 associated with an outbreak of hemolytic-uremic syndrome. J Clin Microbiol 1998; 36: 840–842.
  • lyoda S, Tamura K, Itoh K, et al. Inducible stx2 phages are lysogenized in the enteroaggregative and other phenotypic Escherichia coli 086:HNM isolated from patients. FEMS Microbiol Lett 2000; 191: 7–10.
  • Mellmann A, Harmsen D, Cummings CA, et al. Prospective Genomic Charac-terization of the German Enterohemorrhagic Escherichia coli 0104:H4 Outbreak by Rapid Next Generation Sequencing Technology. PLoS One 2011; 6: e22751.
  • Rasko DA, Webster DR, Sahl JW, et al. Origins of the E. coli strain causing an outbreak of hemolytic-uremic syndrome in Germany. N Engl J Med 2011; 365: 709–717.
  • Rohde H, Qin J, Cui Y, et al. Open-source genomic analysis of Shiga-toxin-producing E. coli 0104:H4. N Engl J Med 2011; 365:718–724.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.